Works by Butterton, Joan R

Results: 32

Assessment of Drug Interaction Potential Between the Hepatitis C Virus Direct‐Acting Antiviral Agents Elbasvir/Grazoprevir and the Nucleotide Analog Reverse‐Transcriptase Inhibitor Tenofovir Disoproxil Fumarate.

Published in:

Clinical Pharmacology in Drug Development, 2019, v. 8, n. 7, p. 962, doi. 10.1002/cpdd.701

By:

Feng, Hwa‐Ping;
Guo, Zifang;
Caro, Luzelena;
Talaty, Jennifer E.;
Mangin, Eric;
Panebianco, Deborah;
Fandozzi, Christine;
Zhu, Yali;
Marshall, William;
Huang, Xiaobi;
Hanley, William D.;
Jumes, Patricia;
Valesky, Robert;
Martinho, Monika;
Butterton, Joan R.;
Iwamoto, Marian;
Yeh, Wendy W.

Publication type:

Article

Spontaneous tandem amplification and deletion of the Shiga toxin operon in Shigella dysenteriae 1.

Published in:

Molecular Microbiology, 1999, v. 34, n. 5, p. 1058, doi. 10.1046/j.1365-2958.1999.01669.x

By:

McDonough, Marie A;
Butterton, Joan R

Publication type:

Article

Randomized, Double-blind, Multicenter Trial Comparing Efficacy and Safety of Imipenem/Cilastatin/Relebactam Versus Piperacillin/Tazobactam in Adults With Hospital-acquired or Ventilator-associated Bacterial Pneumonia (RESTORE-IMI 2 Study).

Published in:

Clinical Infectious Diseases, 2021, v. 73, n. 11, p. e4539, doi. 10.1093/cid/ciaa803

By:

Titov, Ivan;
Wunderink, Richard G;
Roquilly, Antoine;
Gonzalez, Daniel Rodríguez;
David-Wang, Aileen;
Boucher, Helen W;
Kaye, Keith S;
Losada, Maria C;
Du, Jiejun;
Tipping, Robert;
Rizk, Matthew L;
Patel, Munjal;
Brown, Michelle L;
Young, Katherine;
Kartsonis, Nicholas A;
Butterton, Joan R;
Paschke, Amanda;
Chen, Luke F

Publication type:

Article

Reply to Chao and Lai.

Published in:

Clinical Infectious Diseases, 2021, v. 73, n. 8, p. 1552, doi. 10.1093/cid/ciab391

By:

Wunderink, Richard G;
Roquilly, Antoine;
Croce, Martin;
Gonzalez, Daniel Rodriguez;
Fujimi, Satoshi;
Butterton, Joan R;
Broyde, Natasha;
Popejoy, Myra W;
Kim, Jason Y;
Anda, Carisa De

Publication type:

Article

A Phase 3, Randomized, Double-Blind Study Comparing Tedizolid Phosphate and Linezolid for Treatment of Ventilated Gram-Positive Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia.

Published in:

Clinical Infectious Diseases, 2021, v. 73, n. 3, p. e710, doi. 10.1093/cid/ciab032

By:

Wunderink, Richard G;
Roquilly, Antoine;
Croce, Martin;
Gonzalez, Daniel Rodriguez;
Fujimi, Satoshi;
Butterton, Joan R;
Broyde, Natasha;
Popejoy, Myra W;
Kim, Jason Y;
Anda, Carisa De

Publication type:

Article

Reply to Sfeir.

Published in:

2021

By:

Motsch, Johann;
Young, Katherine;
Brown, Michelle L;
Butterton, Joan R;
Paschke, Amanda

Publication type:

Letter to the Editor

RESTORE-IMI 1: A Multicenter, Randomized, Double-blind Trial Comparing Efficacy and Safety of Imipenem/Relebactam vs Colistin Plus Imipenem in Patients With Imipenem-nonsusceptible Bacterial Infections.

Published in:

Clinical Infectious Diseases, 2020, v. 70, n. 9, p. 1799, doi. 10.1093/cid/ciz530

By:

Motsch, Johann;
Oliveira, Cláudia Murta de;
Stus, Viktor;
Köksal, Iftihar;
Lyulko, Olexiy;
Boucher, Helen W;
Kaye, Keith S;
File, Thomas M;
Brown, Michelle L;
Khan, Ireen;
Du, Jiejun;
Joeng, Hee-Koung;
Tipping, Robert W;
Aggrey, Angela;
Young, Katherine;
Kartsonis, Nicholas A;
Butterton, Joan R;
Paschke, Amanda

Publication type:

Article

A Mortality Analysis of Letermovir Prophylaxis for Cytomegalovirus (CMV) in CMV-seropositive Recipients of Allogeneic Hematopoietic Cell Transplantation.

Published in:

Clinical Infectious Diseases, 2020, v. 70, n. 8, p. 1525, doi. 10.1093/cid/ciz490

By:

Ljungman, Per;
Schmitt, Michael;
Marty, Francisco M;
Maertens, Johan;
Chemaly, Roy F;
Kartsonis, Nicholas A;
Butterton, Joan R;
Wan, Hong;
Teal, Valerie L;
Sarratt, Kendra;
Murata, Yoshihiko;
Leavitt, Randi Y;
Badshah, Cyrus

Publication type:

Article

A novel murine infection model for Shiga toxin-producing Escherichia coli.

Published in:

Journal of Clinical Investigation, 2012, v. 122, n. 11, p. 4012, doi. 10.1172/JCI62746

By:

Mallick, Emily M.;
McBee, Megan E.;
Vanguri, Vijay K.;
Melton-Celsa, Angela R.;
Schlieper, Katherine;
Karalius, Brad J.;
O'Brien, Alison D.;
Butterton, Joan R.;
Leong, John M.;
Schauer, David B.

Publication type:

Article

Impact of renal impairment and human organic anion transporter inhibition on pharmacokinetics, safety and tolerability of relebactam combined with imipenem and cilastatin.

Published in:

British Journal of Clinical Pharmacology, 2020, v. 86, n. 5, p. 944, doi. 10.1111/bcp.14204

By:

Bhagunde, Pratik;
Colon‐Gonzalez, Francheska;
Liu, Yang;
Wu, Jin;
Xu, Shiyao Sherrie;
Garrett, Graigory;
Jumes, Patricia;
Lasseter, Kenneth;
Marbury, Thomas;
Rizk, Matthew L.;
Lala, Mallika;
Rhee, Elizabeth G.;
Butterton, Joan R.;
Boundy, Keith

Publication type:

Article

Pharmacokinetics of elbasvir and grazoprevir in subjects with end-stage renal disease or severe renal impairment.

Published in:

European Journal of Clinical Pharmacology, 2019, v. 75, n. 5, p. 665, doi. 10.1007/s00228-018-2585-3

By:

Caro, Luzelena;
Wenning, Larissa;
Feng, Hwa-Ping;
Guo, Zifang;
Du, Lihong;
Bhagunde, Pratik;
Fandozzi, Christine;
Panebianco, Deborah;
Marshall, William L.;
Butterton, Joan R.;
Iwamoto, Marian;
Yeh, Wendy W.

Publication type:

Article

Erratum to: A Two-Way Steady-State Pharmacokinetic Interaction Study of Doravirine (MK-1439) and Dolutegravir.

Published in:

2017

By:

Anderson, Matt;
Khalilieh, Sauzanne;
Yee, Ka;
Liu, Rachael;
Fan, Li;
Rizk, Matthew;
Shah, Vedangi;
Hussaini, Azra;
Song, Ivy;
Ross, Lisa;
Butterton, Joan;
Anderson, Matt S;
Yee, Ka Lai;
Rizk, Matthew L;
Ross, Lisa L;
Butterton, Joan R

Publication type:

journal article

A Two-Way Steady-State Pharmacokinetic Interaction Study of Doravirine (MK-1439) and Dolutegravir.

Published in:

2017

By:

Anderson, Matt;
Khalilieh, Sauzanne;
Yee, Ka;
Liu, Rachael;
Fan, Li;
Rizk, Matthew;
Shah, Vedangi;
Hussaini, Azra;
Song, Ivy;
Ross, Lisa;
Butterton, Joan;
Anderson, Matt S;
Yee, Ka Lai;
Rizk, Matthew L;
Ross, Lisa L;
Butterton, Joan R

Publication type:

journal article

Grazoprevir-Elbasvir Combination Therapy for Treatment-Naive Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection: A Randomized Trial.

Published in:

2015

By:

Zeuzem, Stefan;
Ghalib, Reem;
Reddy, K Rajender;
Pockros, Paul J;
Ari, Ziv Ben;
Zhao, Yue;
Brown, Deborah D;
Wan, Shuyan;
DiNubile, Mark J;
Nguyen, Bach-Yen;
Robertson, Michael N;
Wahl, Janice;
Barr, Eliav;
Butterton, Joan R;
Ben Ari, Ziv

Publication type:

journal article

Grazoprevir-Elbasvir Combination Therapy for Treatment-Naive Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection.

Published in:

Annals of Internal Medicine, 2015, v. 163, n. 1, p. 1, doi. 10.7326/M15-0785

By:

Zeuzem, Stefan;
Ghalib, Reem;
Reddy, Rajender;
Pockros, Paul J.;
Ben Ari, Ziv;
Yue Zhao;
Brown, Deborah D.;
Shuyan Wan;
DiNubile, Mark J.;
Bach-Yen Nguyen;
Robertson, Michael N.;
Wahl, Janice;
Barr, Eliav;
Butterton, Joan R.

Publication type:

Article

Pharmacokinetic Interactions Between the Hepatitis C Virus Protease Inhibitor Boceprevir and Ritonavir-Boosted HIV-1 Protease Inhibitors Atazanavir, Darunavir, and Lopinavir.

Published in:

Clinical Infectious Diseases, 2013, v. 56, n. 5, p. 718, doi. 10.1093/cid/cis968

By:

Hulskotte, Ellen G. J.;
Feng, Hwa-Ping;
Xuan, Fengjuan;
van Zutven, Marga G. J. A.;
Treitel, Michelle A.;
Hughes, Eric A.;
O'Mara, Edward;
Youngberg, Stephen P.;
Wagner, John A.;
Butterton, Joan R.

Publication type:

Article

No Pharmacokinetic Interactions Between Elbasvir or Grazoprevir and Buprenorphine/Naloxone in Healthy Participants and Participants Receiving Stable Opioid Agonist Therapy.

Published in:

CTS: Clinical & Translational Science, 2018, v. 11, n. 6, p. 562, doi. 10.1111/cts.12565

By:

Feng, Hwa‐Ping;
Guo, Zifang;
Caro, Luzelena;
Marshall, William L.;
Liu, Fang;
Panebianco, Deborah;
Vaddady, Pavan;
Barbour, April;
Reitmann, Christina;
Jumes, Patricia;
Gilmartin, Jocelyn;
Wolford, Dennis;
Valesky, Robert;
Martinho, Monika;
Butterton, Joan R.;
Iwamoto, Marian;
Fraser, Iain;
Webster, Lynn;
Yeh, Wendy W.

Publication type:

Article

No Pharmacokinetic Interactions Between Elbasvir or Grazoprevir and Methadone in Participants Receiving Maintenance Opioid Agonist Therapy.

Published in:

CTS: Clinical & Translational Science, 2018, v. 11, n. 6, p. 553, doi. 10.1111/cts.12564

By:

Feng, Hwa‐Ping;
Guo, Zifang;
Caro, Luzelena;
Marshall, William L.;
Liu, Fang;
Panebianco, Deborah;
Vaddady, Pavan;
Reitmann, Christina;
Jumes, Patricia;
Wolford, Dennis;
Fraser, Iain;
Valesky, Robert;
Martinho, Monika;
Butterton, Joan R.;
Iwamoto, Marian;
Webster, Lynn;
Yeh, Wendy W.

Publication type:

Article

Evaluation of Renal Safety Between Imipenem/Relebactam and Colistin Plus Imipenem in Patients With Imipenem-Nonsusceptible Bacterial Infections in the Randomized, Phase 3 RESTORE-IMI 1 Study.

Published in:

Open Forum Infectious Diseases, 2020, v. 7, n. 3, p. N.PAG, doi. 10.1093/ofid/ofaa054

By:

Brown, Michelle L;
Motsch, Johann;
Kaye, Keith S;
File, Thomas M;
Boucher, Helen W;
Vendetti, Neika;
Aggrey, Angela;
Joeng, Hee-Koung;
Tipping, Robert W;
Du, Jiejun;
DePestel, Daryl D;
Butterton, Joan R;
Paschke, Amanda

Publication type:

Article

471. Safety and Efficacy of Oral and/or Intravenous Tedizolid Phosphate (TZD) in Adolescents with Acute Bacterial Skin and Skin Structure Tissue Infections (ABSSSI).

Published in:

Open Forum Infectious Diseases, 2019, v. 6, p. S230, doi. 10.1093/ofid/ofz360.544

By:

Bradley, John S;
Antadze, Tinatin;
Mitha, Ismail H;
Ninov, Borislav;
Tayob, Mohammed S;
Broyde, Natasha;
Butterton, Joan R;
Chou, Margaret Z;
Anda, Carisa S De;
Kim, Jason Y;
Sears, Pamela S

Publication type:

Article

2841. A Phase 3, Randomized, Double-Blind Study Comparing Tedizolid Phosphate (TZD) and Linezolid (LZD) for Treatment of Ventilated Gram-Positive (G+) Nosocomial Pneumonia.

Published in:

Open Forum Infectious Diseases, 2019, v. 6, p. S67, doi. 10.1093/ofid/ofz359.146

By:

Wunderink, Richard G;
Roquilly, Antoine;
Croce, Martin;
Gonzalez, Daniel Rodriguez;
Fujimi, Satoshi;
Butterton, Joan R;
Broyde, Natasha;
Popejoy, Myra W;
Kim, Jason Y;
Anda, Carisa S De

Publication type:

Article

2226. Impact of Prior and Concomitant Antibacterial Therapy on Outcomes in the ASPECT-NP Randomized, Controlled Trial of Ceftolozane/Tazobactam (C/T) vs. Meropenem (MEM) in Patients with Ventilated Nosocomial Pneumonia (NP).

Published in:

Open Forum Infectious Diseases, 2019, v. 6, p. S760, doi. 10.1093/ofid/ofz360.1904

By:

Wunderink, Richard G;
Bruno, Christopher;
Martin-Loeches, Ignacio;
Kollef, Marin;
Timsit, Jean-Francois;
Yu, Brian;
Huntington, Jennifer A;
Li, Linping;
Jensen, Erin;
Wolf, Dominik;
Butterton, Joan R;
Rhee, Elizabeth G

Publication type:

Article

Ceftolozane/tazobactam versus meropenem in patients with ventilated hospital-acquired bacterial pneumonia: subset analysis of the ASPECT-NP randomized, controlled phase 3 trial.

Published in:

2021

By:

Timsit, Jean-François;
Huntington, Jennifer A.;
Wunderink, Richard G.;
Shime, Nobuaki;
Kollef, Marin H.;
Kivistik, Ülo;
Nováček, Martin;
Réa-Neto, Álvaro;
Martin-Loeches, Ignacio;
Yu, Brian;
Jensen, Erin H.;
Butterton, Joan R.;
Wolf, Dominik J.;
Rhee, Elizabeth G.;
Bruno, Christopher J.

Publication type:

journal article

Characterization of a Vibrio cholerae virulence factor homologous to the family of TonB-dependent proteins.

Published in:

Molecular Microbiology, 1992, v. 6, n. 16, p. 2407, doi. 10.1111/j.1365-2958.1992.tb01415.x

By:

Goldberg, Marcia B.;
Boyko, Stephanie A.;
Butterton, Joan R.;
Stoebner, Janice A.;
Payne, Shelley M.;
Calderwood, Stephen B.

Publication type:

Article

Evaluation of Pharmacokinetic Drug Interactions of the Direct-Acting Antiviral Agents Elbasvir and Grazoprevir with Pitavastatin, Rosuvastatin, Pravastatin, and Atorvastatin in Healthy Adults.

Published in:

Clinical Drug Investigation, 2021, v. 41, n. 2, p. 133, doi. 10.1007/s40261-020-00974-8

By:

Caro, Luzelena;
Prueksaritanont, Thomayant;
Fandozzi, Christine M.;
Feng, Hwa-Ping;
Guo, Zifang;
Wolford, Dennis;
Panebianco, Deborah;
Fraser, Iain P.;
Levine, Vanessa;
Swearingen, Dennis;
Butterton, Joan R.;
Iwamoto, Marian;
Yeh, Wendy W.

Publication type:

Article

Pharmacokinetics and Tolerability of Letermovir Coadministered With Azole Antifungals (Posaconazole or Voriconazole) in Healthy Subjects.

Published in:

Journal of Clinical Pharmacology, 2018, v. 58, n. 7, p. 897, doi. 10.1002/jcph.1094

By:

Marshall, William L.;
McCrea, Jacqueline B.;
Macha, Sreeraj;
Menzel, Karsten;
Liu, Fang;
van Schanke, Arne;
de Haes, Joanna I. Udo;
Hussaini, Azra;
Jordan, Heather R.;
Drexel, Melissa;
Kantesaria, Bhavna S.;
Tsai, Christine;
Cho, Carolyn R.;
Hulskotte, Ellen G. J.;
Butterton, Joan R.;
Iwamoto, Marian

Publication type:

Article

Pharmacokinetic Interactions Between Elbasvir/Grazoprevir and Immunosuppressant Drugs in Healthy Volunteers.

Published in:

Journal of Clinical Pharmacology, 2018, v. 58, n. 5, p. 666, doi. 10.1002/jcph.1052

By:

Feng, Hwa‐Ping;
Caro, Luzelena;
Fandozzi, Christine M.;
Guo, Zifang;
Talaty, Jennifer;
Wolford, Dennis;
Panebianco, Deborah;
Iwamoto, Marian;
Butterton, Joan R.;
Yeh, Wendy W.

Publication type:

Article

Characterisation of the absorption, distribution, metabolism, excretion and mass balance of doravirine, a non-nucleoside reverse transcriptase inhibitor in humans.

Published in:

Xenobiotica, 2019, v. 49, n. 4, p. 422, doi. 10.1080/00498254.2018.1451667

By:

Sanchez, Rosa I.;
Fillgrove, Kerry L.;
Yee, Ka Lai;
Liang, Yuexia;
Lu, Bing;
Tatavarti, Aditya;
Liu, Rachael;
Anderson, Matt S.;
Behm, Martin O.;
Fan, Li;
Li, Yun;
Butterton, Joan R.;
Iwamoto, Marian;
Khalilieh, Sauzanne G.

Publication type:

Article

Fabry Disease in Mice Protects against Lethal Disease Caused by Shiga Toxin-Expressing Enterohemorrhagic Escherichia coli.

Published in:

Journal of Infectious Diseases, 2006, v. 194, n. 8, p. 1135, doi. 10.1086/507705

By:

Cilmi, Salvatore A.;
Karalius, Brad J.;
Choy, Wendy;
Smith, R. Neal;
Butterton, Joan R.

Publication type:

Article

Renal Injury Is a Consistent Finding in Dutch Belted Rabbits Experimentally Infected with Enterohemorrhagic Escherichia coli.

Published in:

Journal of Infectious Diseases, 2006, v. 193, n. 8, p. 1125, doi. 10.1086/501364

By:

García, Alexis;
Bosques, Carlos J.;
Wishnok, John S.;
Yan Feng;
Karalius, Brad J.;
Butterton, Joan R.;
Schauer, David B.;
Rogers, Arlin B.;
Fox, James G.

Publication type:

Article

Clinical and microbiological outcomes, by causative pathogen, in the ASPECT-NP randomized, controlled, Phase 3 trial comparing ceftolozane/tazobactam and meropenem for treatment of hospital-acquired/ventilator-associated bacterial pneumonia.

Published in:

2022

By:

Martin-Loeches, Ignacio;
Timsit, Jean-François;
Kollef, Marin H.;
Wunderink, Richard G.;
Shime, Nobuaki;
Nováček, Martin;
Kivistik, Ülo;
Réa-Neto, Álvaro;
Bruno, Christopher J.;
Huntington, Jennifer A.;
Lin, Gina;
Jensen, Erin H.;
Motyl, Mary;
Yu, Brian;
Gates, Davis;
Butterton, Joan R.;
Rhee, Elizabeth G.

Publication type:

journal article

Assessment of drug interaction potential between the HCV direct-acting antiviral agents elbasvir/grazoprevir and the HIV integrase inhibitors raltegravir and dolutegravir.

Published in:

2019

By:

Feng, Hwa-Ping;
Guo, Zifang;
Ross, Lisa L;
Fraser, Iain;
Panebianco, Deborah;
Jumes, Patricia;
Fandozzi, Christine;
Caro, Luzelena;
Talaty, Jennifer;
Ma, Joanne;
Mangin, Eric;
Huang, Xiaobi;
Marshall, William L;
Butterton, Joan R;
Iwamoto, Marian;
Yeh, Wendy W

Publication type:

journal article